A Study of SPH3127 in the Treatment of Mild to Moderate Ulcerative Colitis
Clinical trial NCT05770609 · COMPLETED
Trial details
- NCT number
- NCT05770609
- Sponsor
- Shanghai Pharmaceuticals Holding Co., Ltd
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-19
- Primary completion
- 2024-09-13
- Enrollment
- 53
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.